List of Advarra OnCore Customers
Columbia, 21044, MD,
United States
Since 2010, our global team of researchers has been studying Advarra OnCore customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Advarra OnCore for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Advarra OnCore for Clinical Trial Management include: University of Kentucky, a United States based Education organisation with 13500 employees and revenues of $5.45 billion, Duke University Health System, a United States based Healthcare organisation with 23462 employees and revenues of $4.84 billion, Yale University, a United States based Education organisation with 14800 employees and revenues of $4.20 billion and many others.
Contact us if you need a completed and verified list of companies using Advarra OnCore, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Advarra OnCore customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Duke University Health System | Healthcare | 23462 | $4.8B | United States | Advarra | Advarra OnCore | Clinical Trial Management | 2016 | n/a | In 2016 Duke University Health System selected Advarra OnCore as its CTMS following a formal contract review that year, launching an enterprise program to standardize clinical trial operations across research units. The selection initiated configuration and program planning that culminated in an enterprise big bang OnCore go live on May 21, 2018. The deployment centered on Advarra OnCore modules for enrollment tracking, study-level reporting, and financial workflow management, with an explicit planned roll out of OnCore Financials. Configuration work addressed accrual and enrollment processes, study financial setups, reporting models, and automation of clinical research administrative workflows consistent with CTMS functional patterns. Advarra OnCore was integrated with Epic for clinical data alignment, with SAP for financial interfacing, and with a new IRB system to centralize regulatory status and approvals. The SAP interfacing work was scoped to improve study financials and reporting by feeding study-level financials into enterprise finance processes. Governance for the deployment centralized research study lifecycle oversight and standardized enrollment tracking, reporting, and financial workflows across Duke research units, with a coordinated enterprise rollout approach. The program documented a staged activation of OnCore Financials and SAP interfaces as part of the broader CTMS implementation and operational handoff to research administration teams. | |
|
|
University of Kentucky | Education | 13500 | $5.5B | United States | Advarra | Advarra OnCore | Clinical Trial Management | 2006 | n/a | In 2006 University of Kentucky implemented Advarra OnCore, Apps Category: . The Markey Cancer Center fully implemented the OnCore Enterprise Research System that year to centralize clinical trial management and reporting and to support its National Cancer Institute designation effort. Advarra OnCore was positioned as the authoritative system for protocol tracking and portfolio-level reporting across the cancer center. Implementation emphasis focused on clinical trial management and enterprise reporting, with configuration to centralize protocol lifecycle information and portfolio management data. The deployment consolidated trial status, enrollment tracking, and reporting workflows into Advarra OnCore, and the center documented plans to add biospecimen management functionality within OnCore to extend specimen tracking and inventory oversight. Operational coverage was confined to the Markey Cancer Center within the University of Kentucky, supplying the reporting and portfolio management data used in the NCI application process. Governance changes included centralizing reporting ownership and portfolio oversight in OnCore to support compliance and the NCI submission, and the system helped the center secure NCI designation in 2013. | |
|
|
Yale University | Education | 14800 | $4.2B | United States | Advarra | Advarra OnCore | Clinical Trial Management | 2013 | n/a | In 2013, Yale University adopted Advarra OnCore as its institutional CTMS. Yale University implemented Advarra OnCore CTMS to centralize clinical trial management and to support research administration and clinical care coordination across its academic medical enterprise. The deployment emphasized billing and EMR interface capabilities, with Advarra OnCore configured to handle demographics, study status flags, laboratory results, and billing designations. Module usage for billing and EMR interfaces is inferred from the cited case study and institutional documentation, consistent with typical CTMS functional workflows for participant tracking and charge assignment. In 2013 Yale integrated OnCore with its Epic EHR to enable bidirectional data exchange of demographics, study status flags, lab results, and billing designations. The US based integration connected research systems to clinical workflows, improving visibility for care teams and aligning study status and lab data between the CTMS and the electronic health record. Governance and operational alignment routed responsibilities to research administration and clinical informatics groups, ensuring data exchange supported billing compliance and participant safety monitoring. The integration is documented to have improved billing compliance and participant safety visibility across care teams, as reported in institutional materials. |
Buyer Intent: Companies Evaluating Advarra OnCore
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||